The effects of exercise training on quality of life in HAART-treated HIV-positive Rwandan subjects with body fat redistribution
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Our objective was to examine the effects of exercise training (EXS) on quality of life (QoL) in highly active antiretroviral therapy (HAART)-treated HIV-positive (HIV+) subjects with body fat redistribution (BFR) in Rwanda.
The effects of a randomised controlled trial of EXS on QoL were measured using World Health Organisation Quality of Life (WHOQOL)-BREF in HIV+ subjects with BFR randomised to EXS (n = 50; BFR + EXS) or no exercise training (n = 50; BFR + noEXS).
At 6 months, scores on the psychological [1.3 (0.3) vs. 0.5 (0.1); P < 0.0001], independence [0.6 (0.1) vs. 0.0 (0.0); P < 0.0001], social relationships [0.6 (0.2) vs. 0.0 (0.0); P < 0.0001] and HIV HAART-specific QoL domains [1.4 (0.2) vs. −0.1 (0.2); P < 0.0001] improved more in BFR + EXS than BFR + noEXS group, respectively. Self-esteem [1.3 (0.8) vs. 0.1 (0.6); P < 0.001], body image [1.5 (0.6) vs. 0.0 (0.5); P < 0.001] and emotional stress [1.6 (0.7) vs. 0.2 (0.5); P < 0.001] improved more in the BFR + EXS group than BFR + noEXS group, respectively. Psychological [1.5 (0.2) vs. 1.1 (0.3); P < 0.0001], social relationship [0.8 (0.2) vs. 0.4 (0.2); P < 0.0001], and HIV HAART-specific well-being [1.8 (0.2) vs. 1.0 (0.0); P < 0.0001] improved more in BFR + EXS female than male subjects.
Exercise training improved several components of QoL in HAART-treated HIV+ African subjects with BFR. Exercise training is an inexpensive and efficacious strategy for improving QoL in HIV+ African subjects, which may improve HAART adherence and treatment initiatives in resource-limited areas of sub-Saharan Africa.
- Egger, M., May, M., Chene, G., et al. (2002). Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet, 360, 119–129. CrossRef
- Chen, D., Mistra, A., & Garg, A. (2002). Lipodystrophy in human immunodeficiency virus-infected patients. The Journal of Clinical Endocrinology and Metabolism, 87, 4845–4856. CrossRef
- Pujari, S. N., Dravid, A., Naik, E., et al. (2005). Lipodystrophy and dyslipidaemia among patients taking first-line, World Health Organisation-recommended highly active antiretroviral therapy regimens in Western India. Journal of Acquired Immune Deficiency Syndromes, 39, 199–202.
- Reynolds, N. R., Neidig, J. L., Wu, A. W., et al. (2006). Balancing disfigurement and fear of disease progression: Patient perceptions of HIV fat redistribution. AIDS Care, 18, 663–673. CrossRef
- Beck, E. J., Vitoria, M., Mandalia, S., et al. (2006). National adult antiretroviral therapy guidelines in resource-limited countries: Concordance with 2003 WHO guidelines? AIDS, 11, 1497–1502. CrossRef
- Ammassari, A., Antinori, A., Cozzi-Lepri, A., et al. (2002). Relationship Between HAART Adherence and Adipose Tissue Alterations. Journal of Acquired Immune Deficiency Syndromes, 31, S140–S144.
- Tramarin, A., Campostrini, S., Postma, M. J., et al. (2004). A multicentre study of patient survival, disability, quality of life and cost of care: Among patients with AIDS in northern Italy. Pharmacoeconomics, 22, 43–53. CrossRef
- Steel, J. L., Landsittel, D., Calhoun, B., et al. (2006). Effects of lipodystrophy on quality of life and depression in HIV-infected men on HAART. AIDS Patient Care and STDs, 20, 565–575. CrossRef
- Blanch, J., Rousaud, A., Martinez, E., et al. (2004). Factors associated with severe impact of lipodystrophy on quality of life of patients infected with HIV-1. Clinical Infectious Disease, 38, 1464–1470. CrossRef
- Jacobson, D. L., Knox, T., Spiegelman, D., et al. (2005). Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women. Clinical Infectious Disease, 40, 1837–1845. CrossRef
- Wohl, D. A. (2004). Diagnosis and management of body morphology changes and lipid abnormalities associated with HIV Infection and its therapies. Topics in HIV Medicine, 12, 89–93.
- Dube, M. P., Stein, J. H., Aberg, J. A., et al. (2003). Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: Recommendations of the HIV Medicine Association of America and the Adult AIDS Clinical Trials Group. Clinical Infectious Disease, 37, 613–627. CrossRef
- Ciccolo, J. T., Jowers, E. M., & Bartholomew, J. B. (2004). The benefits of exercise training for quality of life in HIV/AIDS in the post-HAART era. Sports Medicine, 34, 487–499. CrossRef
- Stringer, W. W., Berezovskava, M., O’Brien WA, et al. (1998). The effects of exercise training on aerobic fitness, immune indices, and quality of life in HIV positive patients. Medicine and Science in Sports and Exercise, 30, 11–16.
- Bartholomew, J. B., & Miller, B. M. (2002). Affective responses to an aerobic dance class: the impact of perceived performance. Research Quarterly for Exercise and Sport, 73, 301–309.
- Burnham, T. R., & Wilcox, A. (2002). Effects of exercise on physiological and psychological variables in cancer survivors. Medicine and Science in Sports and Exercise, 34, 1863–1867. CrossRef
- Lichtenstein, K. A., Ward, D. J., & Moorman, A. C. (2001). Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS, 15, 1389–1398. CrossRef
- Carr, A., Emery, S., Law, M., et al. (2003). An objective case definition of lipodystrophy in HIV-infected adults: A case-control study. Lancet, 361, 726–735. CrossRef
- Wilkinson, D. M., Fallowfield, J. L., & Myers, S. D. (1999). A modified incremental shuttle run test for the determination of peak shuttle running speed and the prediction of maximal oxygen uptake. Journal of Sports Sciences, 17, 413–419. CrossRef
- Flouris, A. D., Metsios, G. S., & Koutedakis, Y. (2005). Enhancing the efficacy of the 20 m Multi-stage run test. British Journal of Sports Medicine, 39, 166–170. CrossRef
- Hsiung, P., Fang, C., Chang, Y. Y., et al. (2005). Comparison of WHOQOL-BREF and SF-36 in patients with HIV infection. Quality of Life Research, 14, 141–150. CrossRef
- O’Connell, K., Saxena, S., Skevington, S., et al. (2004). WHOQOL-HIV Quality of Life assessment among people living with HIV and AIDS: results from the field test. AIDS Care, 16, 882–889. CrossRef
- Guaraldi, G., Orlando, G., Murri, R., et al. (2006). Quality of life and body image in the assessment of psychological impact of lipodystrophy: Validation of the Italian version of Assessment of Body Change and Distress questionnaire. Quality of Life Research, 15, 173–178. CrossRef
- Durnin, J. V. G. A., & Rahaman, M. M. (1967). The assessment of the amount of fat in the human body from measurements of skinfold thickness. The British Journal of Nutrition, 21, 681–689. CrossRef
- Durnin, J. V. G. A., & Womersley, J. (1974). Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16–72 years. The British Journal of Nutrition, 32, 77–97. CrossRef
- Zillikens, M. C., Conway, J. M. (1990). Anthropometry in blacks: Applicability of generalized skinfold equations and differences in fat patterning between blacks and whites. The American Journal of Clinical Nutrition, 52, 45–51.
- Mutimura, E., Stewart, A., Rheeder, P., et al. (2007). Metabolic function and the prevalence of lipodystrophy in a population of HIV-infected African subjects receiving highly active antiretroviral therapy (HAART). Journal of Acquired Immune Deficiency Syndromes, 46, 451–455. CrossRef
- Liu, C., Ostrow, D., Detels, R., et al. (2006). Impacts of HIV infection and HAART use on quality of life. Quality of Life Research, 15, 941–949. CrossRef
- Holmes, W. C., & Shea, J. A. (1997). Performance of a new HIV/AIDS-targeted quality of life (HAT-QoL) instrument in asymptomatic seropositive individuals. Quality of Life Research, 6, 561–571. CrossRef
- Smith, K. W., Avis, N. E., Mayer, K. H., & Awislow, L. (1997). Use of the MQoL-HIV with asymptomatic HIV-positive patients. Quality of Life Research, 6, 555–560. CrossRef
- Kuyken, W., Orley, J., Sartorius, N., Power, M., Herrman, H., Schofield, H., WHO Group. (1995). The World Health Organisation Quality of life Assessment (WHOQOL): Position paper from the World Health Organisation. Social Science and Medicine, 41, 1403–1409.
- Galantino, M. L., Shepard, K., Krafft, L., et al. (2005). The effect of group aerobic exercise and t’ai chi on functional outcomes and quality of life for persons living with acquired immunodeficiency syndrome. Journal of Alternative and Complementary Medicine, 11, 1085–1092. CrossRef
- Burgoyne, R., & Renwick, R. (2004). Social support and quality of life over time among adults living with HIV in the HAART era. Social Science and Medicine, 58, 1353–1366. CrossRef
- Preau, M., Leport, C., Salmon-Ceron, D., et al. (2004). Health-related quality of life and patient-provider relationships in HIV-infected patients during the first three years after starting PI-containing antiretroviral treatment. AIDS Care, 16, 649–661. CrossRef
- Fillipas, S., Oldmeadow, L. B., Bailey, M. J., et al. (2006). A six-month, supervised, aerobic and resistance exercise program improves self-efficacy in people with human immunodeficiency virus: A randomized controlled trial. The Australian Journal of Physiotherapy, 52, 185–190.
- Scevola, D., Di Matteo, A., Lanzarini, P., et al. (2003). Effect of exercise and strength training on cardiovascular status in HIV-infected patients receiving highly active antiretroviral therapy. AIDS, 17, 123–129. CrossRef
- Korzeniowska-Kubacka, I., Bilińska, M., & Piotrowicz, R. (2007). Influence of physical training on cardiac performance in patients with coronary artery disease and exercise-induced left ventricular dysfunction. Acta Cardiologica, 62, 573–578.
- O’Connor, P. J., & Puetz, T. W. (2005). Chronic physical activity and feelings of energy and fatigue. Medicine and Science in Sports and Exercise, 37, 299–305. CrossRef
- Nicholas, P. K., Kirksey, K. M., Corless, I. B., et al. (2005). Lipodystrophy and quality of life in HIV: Symptom management issues. Applied Nursing Research, 18, 55–58. CrossRef
- Galli, M., Veglia, F., Angarano, G., et al. (2003). Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men to develop particular lipodystrophy patterns. Journal of Acquired Immune Deficiency Syndromes, 34, 58–61. CrossRef
- Kayirangwa, E., Hanson, J., Munyakazi, L., et al. (2006). Current trends in Rwanda’s HIV/AIDS epidemic. Sexually Transmitted Infections, 82, 27–31. CrossRef
- Corless, I. B., Kirksey, K. M., Kemppainen, J., et al. (2005). Lipodystrophy-associated symptoms and medication Adherence in HIV/AIDS. AIDS Patient Care and STDs, 19, 577–586. CrossRef
- Connors, J., & Casey, P. (2006). Sex, body-esteem and self-esteem. Psychological Reports, 98, 699–704. CrossRef
- Jones, S. P., Doran, D., Leatt, P. B., et al. (2001). Short-term exercise training improves body composition and hyperlipidaemia in HIV-positive individuals with lipodystrophy. AIDS, 15, 2049–2051. CrossRef
- Fitch, K., Anderson, E. J., Hubbard, J. L., et al. (2006). Effects of a lifestyle modification program in HIV-infected patients with metabolic syndrome. AIDS, 20, 1843–1850. CrossRef
- Dolan, S. E., Frontera, W., Librizzi, J., et al. (2006). Effects of a supervised home-based aerobic and progressed resistance regimen in women infected with human immunodeficiency virus. Archives of Internal Medicine, 166, 1225–1231. CrossRef
- The effects of exercise training on quality of life in HAART-treated HIV-positive Rwandan subjects with body fat redistribution
Quality of Life Research
Volume 17, Issue 3 , pp 377-385
- Cover Date
- Print ISSN
- Online ISSN
- Springer Netherlands
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Faculty of Allied Health Sciences, Kigali Health Institute, P. O. Box 3286, Kigali, Rwanda
- 2. School of Therapeutic Sciences, University of the Witwatersrand, Johannesburg, South Africa
- 3. Department of Chemical Pathology, National Health Laboratory Service, University of the Witwatersrand, Johannesburg, South Africa
- 4. Division of Endocrinology, Metabolism & Lipid Research, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA
- 5. Program in Physical Therapy, Washington University School of Medicine, St. Louis, MO, USA